0241 (0241) Fair Value & Analysis
Healthcare · Market cap HK$49.7B
Fair value as of: Jul 1, 2026
From 26 valuation models · updated today
Share price −15.2% over the past month.
Price vs Fair Value (12 months)
12‑month range HK$3.07 – HK$7.78 · fair‑value band HK$1.59 – HK$2.55 · the HK$3.08 price screens above the HK$2.04 fair value. As of Jul 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
0241 (0241) currently trades at HK$3.08, while our model-based Fair Value estimate is HK$2.04 — implying the stock looks roughly 33.8% overvalued today. We read business quality at 48/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, 0241 generated revenue of HK$34.3B at a net margin of 5.7%. Revenue grew 7.6% year over year. It earns a return on equity of 11.3%. The balance sheet holds a net cash position of HK$5.7B. Fundamentals as of Jul 1, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
0241 reported revenue of HK$34.3B in FY2026 versus HK$20.6B in FY2022, a compound +13.6%/yr. Reported net income was HK$1.9B in FY2026.
Is 0241 fairly valued? → Check now
Recent news
- Asian Penny Stock Insights For June 2026
- Asian Penny Stocks With Market Caps Over US$1B
- Health Care Roundup: Market Talk
- AI App Makers Drive China Tech Rally as Investors Chase Profits
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
6 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| JD Health International Inc JDHIF | $5.85 | $7.13 | +22% |
| Alibaba Health Information Technology Limited ALBBY | $8.27 | $6.61 | -20% |
| Raia Drogasil S.A RADL3 | R$17.46 | R$16.13 | -8% |
| Yifeng Pharmacy Chain Co 603939 | ¥20.91 | ¥22.00 | +5% |
| Clicks Group CLCGY | $29.02 | $34.57 | +19% |
| Sugi Holdings SGIPF | $16.29 | $64.34 | +295% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is 0241 (0241) undervalued?
What is the fair value of 0241?
What is the quality score of 0241?
What is the revenue of 0241 (0241)?
What is the net profit margin of 0241?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.